1.Clinical analysis of primary squamous cell carcinoma of the breast.
Chinese Journal of Surgery 2003;41(3):183-185
OBJECTIVETo study the clinicopathological features of primary squamous cell carcinoma (SCC) of breast and the diagnosis and treatment of the disease.
METHODSThe clinical, operative and pathological data from 7 cases of SCC of breast were retrospectively analysed.
RESULTSFive patients complained of painless mass and two of them were accompanied with local pain. All patients were diagnosed as having SCC by fine-needle aspiration before operation. Two patients underwent modified radical mastectomy, and the others received radical mastectomy. Pathological examination showed primary squamous cell carcinoma of the breast with metastasis to axlliary lymph nodes in one patient. Follow-up of four patients revealed that two patients are living well and two patients died. Three patients lost to follow up.
CONCLUSIONThe diagnosis of primary squamous cell carcinoma of the breast is dependent on pathological results. Radical mastectomy including modified radical mastectomy is most effective in the treatment of mammary SCC. Postoperative chemotherapy and radiation are necessary auxiliary therapy.
Adult ; Aged ; Breast Neoplasms ; diagnosis ; pathology ; therapy ; Carcinoma, Squamous Cell ; diagnosis ; pathology ; therapy ; Female ; Humans ; Middle Aged ; Prognosis ; Retrospective Studies
2.Unilateral sinonasal disease in 376 adult patients: a retrospective study.
Xin Yan CUI ; Li Qin WANG ; Min YIN ; Xi CHEN ; Mei Ping LU ; Han ZHOU ; Wei Da DONG ; Zhi Bin CHEN ; Lei CHENG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2018;32(6):439-446
OBJECTIVES:
To investigate the clinical and pathological features of patients with unilateral sinonasal disease (USD).
METHODS:
A retrospective analysis was completed on 376 adult patients with USD from January 2015 to December 2016. Their presenting symptoms, nasal endoscope, CT scanning, and pathology were analyzed respectively.
RESULTS:
Among the 267 (71.01%) patients with inflammatory disease, there were 4 pathological types. And there were 8 pathological types in 60 (15.96%) patients with benign tumor. Of the 49 patients with malignant tumor, there were 15 pathological types which included squamous carcinoma, malignant melanoma, and lymphoma, as well as myoepithelial carcinoma and Mesodermal mesoderm. The onset age of inflammation group was younger than that of benign (<0.05) or malignant tumor groups (<0.05). The misdiagnosis rate was 8.33% in benign tumor (5/60), and 10.20% in malignant tumor (5/49). Nasal polyps was the most common misdiagnosis in the groups of benign and malignant tumor.
CONCLUSIONS
The pathology of adult patients with USD is complicated, and no specific clinical feature was found for distinguishing between benign and malignant lesions. The tumor took a quite proportion in adult patients with USD. Therefore, careful consideration should be taken before diagnosing patients with USD in order to reduce misdiagnosis rate.
Adult
;
Carcinoma, Squamous Cell
;
diagnosis
;
pathology
;
therapy
;
Humans
;
Melanoma
;
diagnosis
;
pathology
;
therapy
;
Nasal Cavity
;
Nasal Polyps
;
Nose Neoplasms
;
diagnosis
;
pathology
;
therapy
;
Retrospective Studies
3.Dermatomyositis Associated with Cancer of Unknown Primary Site.
Hyung Il KIM ; Sung Hoon CHUNG ; Jun Eul HWANG ; Sang Ho KIM ; Jae Sook AHN ; Duk Hwan YANG ; Yoe Kyeoung KIM ; Sook Jung YUN ; Sang Hee CHO ; Je Jung LEE ; Ik Joo CHUNG ; Hyeoung Joon KIM
Journal of Korean Medical Science 2007;22(Suppl):S174-S177
Dermatomyositis (DM) is an uncommon inflammatory myopathy with characteristic rash accompanying, or more often preceding, muscle weakness. There is a well-recognized association between DM and several cancers, such as ovarian cancer, breast cancer, melanoma, colon cancer, and non-Hodgkin lymphoma. We report the first case of cancer of unknown primary site associated with DM. A 62-yr-old woman presented to us with both shoulder painful swelling and facial edema. She was diagnosed previously as cancer of unknown primary site, histologically confirmed with squamous cell carcinoma in a pelvic mass. For the following days, she complained of erythematous face followed by progressive weakness of the proximal muscles of upper and lower limbs. The laboratory tests showed an increased muscle enzyme and acute phase reactants. The electromyogram showed the typical findings of DM. After the treatment with high dose steroid and methotrexate, the proximal motor weakness improved, and she received palliative radiation therapy.
Carcinoma, Squamous Cell/complications/diagnosis/pathology
;
Dermatomyositis/*complications/diagnosis/pathology/therapy
;
Female
;
Humans
;
Middle Aged
;
Neoplasms, Unknown Primary/*complications/diagnosis/pathology
5.Primary squamous cell carcinoma of the thyroid: retrospective analysis of 28 cases.
Yong-xia ZHANG ; Bin ZHANG ; Yue-huang WU ; Wen-sheng LIU ; Shao-yan LIU ; Li GAO ; Zhen-gang XU ; Ping-zhang TANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2013;48(2):143-147
OBJECTIVETo investigate the clinicopathological features, treatment outcomes and prognosis of patients with squamous cell carcinoma of the thyroid (SCCT).
METHODSRetrospective review of SCCT cases in our hospital from January 1999 to May 2012. Demographic data and clinical charts, including presenting symptoms, histologic grade of tumor, treatment, and outcome of 28 consecutive patients were obtained. Survival rates and prognostic factors were calculated with SPSS 13.0 software using the Kaplan-Meier method and multivariate Cox model survival analysis.
RESULTSSCCT accounted for only 0.36% of all types of thyroid malignancy. There were 15 males and 13 females, and the median age was 63 years. The presenting symptoms were neck masses (26/28) and hoarse voice (18/28). The 28 SCCTs included 15 high grade tumors, eight intermediate grade tumors and five low grade tumors. According to the UICC 2002 staging criteria, 16 patients were stage IVa, and 12 were stage IVb. Of the 28 patients, 19 underwent surgery plus postoperative radiotherapy, seven underwent surgery alone, and two received radiotherapy alone. The rates of lymph node metastasis and distant metastasis were 60.7% and 25.0%, respectively. The 1-year, 2-year and 5-year overall survival (OS) rate were 50.4%, 25.8% and 19.3%, respectively, and the median overall survival time was 12.2 months. Kaplan-Meier univariate survival analyses indicated that the sizes of the tumors, esophageal invasions and treatment policies are prognostic factors, and multivariate Cox model survival analyses confirmed that the sizes of the tumors and treatment policies were independent factors for OS. Multivariate survival analyses confirmed that the sizes of the tumors and treatment policies were independent factors for OS.
CONCLUSIONSSCCT is a rare malignant tumor with strong invasive ability, high malignancy and poor prognosis. Combined modality therapy was strongly recommended, and surgical resection plus postoperative radiotherapy may be the main treatment protocol for patients with SCCT.
Adult ; Aged ; Carcinoma, Squamous Cell ; diagnosis ; pathology ; therapy ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Thyroid Neoplasms ; diagnosis ; pathology ; therapy ; Treatment Outcome
6.Esophageal cancer: diagnosis and management.
Chinese Journal of Cancer 2010;29(10):843-854
Esophageal cancer is the 7th leading cause of cancer deaths worldwide. While squamous cell carcinoma is the most prevalent histology internationally, adenocarcinoma of the distal esophagus accounts for nearly 50% of cases in developed countries due to the differences in the etiologic factors such as gastroesophageal reflux disease (GERD) and obesity that predominate. While surgery is the mainstay of treatment of this disease, the utilization of chemoradiation, either used postoperatively or neoadjuvantly, has become a standard practice in the United States. What is the optimal management approach is still an area of contention, however, and may be different in different regions around the world. This article reviews some of these controversies, including the role for surgery in patients treated with definitive chemoradiation. At the end, we will also outline recommendations regarding radiotherapy procedures and techniques.
Adenocarcinoma
;
diagnosis
;
epidemiology
;
pathology
;
therapy
;
Carcinoma, Squamous Cell
;
diagnosis
;
epidemiology
;
pathology
;
therapy
;
Chemoradiotherapy
;
Esophageal Neoplasms
;
diagnosis
;
epidemiology
;
pathology
;
therapy
;
Esophagectomy
;
methods
;
Humans
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Risk Factors
7.Successful Treatment of Malignant Superior Vena Cava Syndrome Using a Stent-Graft.
Korean Journal of Radiology 2012;13(2):227-231
We report successful outcomes after endovascular placement of a stent graft in a 74- and a 77-year-old men, both of whom had malignant superior vena cava syndrome caused by squamous cell carcinoma. In each patient, successful palliation of the malignant superior vena cava syndrome was achieved by placement of a stent graft. No procedure-related complications were observed. The patients were asymptomatic until their deaths, seven and 14 months after stent graft placement, respectively.
Aged
;
Biopsy
;
Bronchoscopy
;
Carcinoma, Squamous Cell/*therapy
;
*Endovascular Procedures
;
Humans
;
Male
;
Palliative Care
;
*Stents
;
Superior Vena Cava Syndrome/diagnosis/pathology/*therapy
;
Tomography, X-Ray Computed
8.A Case of Squamous Cell Carcinoma of the Breast in a Patient with Crohn's Disease Taking Azathioprine.
Kyoung Chan PARK ; Dong Uk JU ; Seong Wook HEO ; Jung Il RYU ; Ju Youn CHO ; Eui Jung KIM ; Hoon Kyu OH ; Eun Young KIM
The Korean Journal of Gastroenterology 2012;60(6):373-376
Azathioprine (AZA) treatment in transplant or autoimmune patients and subsequent appearance squamous cell carcinomas at various sites, particularly skin and cervix, has shown a close relationship. However, it remains uncertain whether this is true for the patients with Crohn's disease. We report a case of squamous cell carcinoma of the breast occurred in a 35-year-old female with Crohn's disease taking AZA. She was first diagnosed with Crohn's disease 10 years ago and has taken AZA with 5-aminosalicylic acid (5-ASA) on regular follow up in gastrointestinal department for 9 years. She had no family history of breast cancer. She visited breast cancer clinic due to incidentally found right breast mass. A mastectomy on the right breast was performed and 6.3x5.5 cm mass was removed. The mass was microscopically proven to be poorly differentiated squamous cell carcinoma with focal keratin pearl formation. At age of 25, she was first diagnosed with active Crohn's disease. 5-ASA and corticosteroid induced remission. Then, steroid was tapered off and AZA was maintained at 1 mg/kg due to leukopenia at higher dose. She stopped taking AZA at her discretion during her two pregnancies and reported total of 67 months of AZA medication on her breast cancer diagnosis.
Adult
;
Azathioprine/*therapeutic use
;
Breast Neoplasms/*diagnosis/pathology/therapy
;
Carcinoma, Squamous Cell/*diagnosis/pathology/therapy
;
Colonoscopy
;
Combined Modality Therapy
;
Crohn Disease/*drug therapy
;
Female
;
Humans
;
Immunosuppressive Agents/*therapeutic use
;
Mesalamine/therapeutic use
;
Positron-Emission Tomography
9.Tonsillar carcinoma: analyses of the therapy and prognostic factors.
Xin WANG ; Fang-Yun XIE ; Fei HAN ; Wei-Han HU ; Ji-Shi LI ; Hui-Min XU
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2009;44(10):848-852
OBJECTIVETo retrospectively analyze the therapeutic effect on patients with tonsillar carcinoma and factors affecting their prognosis.
METHODSClinical data of 61 patients pathologically confirmed with tonsillar carcinoma without distant metastasis were analyzed. All the patients were treated in Cancer Center of Sun Yat-sen University from April 1997 to April 2008. There were 2 patients with undifferentiated carcinoma, 26 with poorly differentiated squamous cell carcinoma and 33 with median-well differentiated squamous cell carcinoma. According to the AJCC 2002 staging criteria for head-neck cancers, there were 9 staged I cases, 7 staged II cases, 23 staged III cases and 22 staged IV cases. The treatment was radiotherapy alone in 27 cases, radiotherapy combined with chemotherapy in 23 cases, surgery combined with postoperative radiotherapy in 6 cases, neoadjuvant chemotherapy plus surgery combined with postoperative radiotherapy in 3 cases, radiotherapy with salvage surgery in 2 cases.
RESULTSThe overall 5-year survival rate was 50.2%. For 16 cases with staged I-II staged, there were 8 cases with radiotherapy alone, 5 years survival was 50.0%, 6 cases with surgery combined with postoperative radiotherapy, 5 years survival was 83.3%. The difference between the two treatments was not significant in statistics (P = 0.318). For III-IV staged 45 cases, there were 19 cases with simple radiotherapy, 5 years survival was 51.5%, 21 cases with radiotherapy combined with chemotherapy, 5 years survival was 36.4%, 5 cases with surgery combined with postoperative radiotherapy, 5 years survival was 75.0%. The difference among the three treatments was not significant in statistics (P = 0.239). According to T stages, the 5-year survival rates of stage T1-T4 cases were 91.8%, 46.8%, 29.1%, 0% respectively (chi(2) = 30.168, P < 0.001). Multivariate analysis demonstrated that T stage, therapeutic effect of primary site and cervical metastatic lymph node were the independent prognostic factors (P < 0.05).
CONCLUSIONST stage, the therapeutic effect of primary site and cervical metastatic lymph node were the independent prognostic factors. For I-II staged tonsillar tumor cases, based on organ preservation, were tendency to choice simple radiotherapy. For III-IV staged cases, yet the relationships between therapeutic mode and therapeutic effect still need further researches.
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell ; diagnosis ; pathology ; therapy ; Combined Modality Therapy ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Survival Rate ; Tonsillar Neoplasms ; diagnosis ; pathology ; therapy
10.Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: a retrospective analysis of treatment strategies and prognosis.
Jian-lin LOU ; Liang GUO ; Jian-qiang ZHAO ; Sheng-ye WANG
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2013;48(1):32-36
OBJECTIVETo analyze the treatment strategies and prognosis of squamous cell carcinoma of cervical lymph nodes from an unknown primary site (SCCUP).
METHODSA total of 125 cases with SCCUP was retrospectively analyzed from January 2001 to December 2011. Ninety-seven of the cases were treated with neck dissection (ND), including 24 with classic radical ND, 62 with modified ND and 11 with extended radical ND. Of 125 cases with SCCUP, 72 cases were supplemented with radiotherapy and 52 cases with chemotherapy. Radiotherapy was applied with extensive field in 36 cases, bilateral neck in 15 cases, and ipsilateral neck in 21 cases. The patients were followed up and the Kaplan-Meier method was used to calculate survival curves. Cox's analysis and logistic regression were used to evaluate the prognosis factors for SCCUP.
RESULTSThe 5-year overall survival rate and disease free survival rate of the cohort were 66.2% and 60.0%, respectively. The median survival time was 70 months. Cox's analysis showed N-stage, extracapsular spread, bilateral neck metastasis and ND were independent prognostic factors for SCCUP. Logistic regression suggested that N-stage was the main factor for nodal recurrence or uncontrolled. The primary tumor sites emerged in 27 patients (21.6%) within 3 - 96 months after treatment (median time was 15 months), but only 4 patients (11.1%) existed in 36 cases underwent radiotherapy with extensive field.
CONCLUSIONSN-stage and extracapsular spread are two major factors influencing the prognosis of SCCUP. ND may improve the locoregional control and long-term survival.
Adult ; Aged ; Carcinoma, Squamous Cell ; diagnosis ; secondary ; surgery ; therapy ; Disease-Free Survival ; Female ; Humans ; Logistic Models ; Lymph Nodes ; pathology ; Lymphatic Metastasis ; Male ; Middle Aged ; Neck Dissection ; Neoplasms, Unknown Primary ; diagnosis ; pathology ; surgery ; therapy ; Prognosis ; Retrospective Studies ; Survival Rate ; Young Adult